Implementing a Pharmacist-Led Primary Care Pharmacogenomics Medication Management Service
- PMID: 39166145
- PMCID: PMC11333096
- DOI: 10.24926/iip.v15i2.6178
Implementing a Pharmacist-Led Primary Care Pharmacogenomics Medication Management Service
Abstract
Background: Pharmacogenomics (PGx) is a tool to guide optimal medication selection. Increased demand for personalized medicine and the growing occurrence of chronic diseases are drivers for pharmacogenomic medication management services. A review of implementation models identified a paucity of models delivering these services utilizing pharmacists in primary care. Lack of standardization of this process remains a barrier to widespread implementation within health systems. Purpose: Describe the process of developing an institutional guidance document and applying it to implement a pharmacogenomics medication management service at clinic sites within an integrated health system in the United States. Measure the growth in the number of PGx visits completed. Method: A task force of pharmacists reviewed literature, guidelines, and institutional policies to create a comprehensive guidance document. The document included six minimum practice requirements for implementation in the primary care setting, and six additional recommendations. A retrospective chart review of all face to face, phone and eConsult PGx visit types occurring from January 1, 2022 through September 30, 2022 was conducted. Results: A pharmacist-led pharmacogenomics medication management service is now offered at all primary care sites within the health system. During the study timeframe, 1378 patients had a PGx visit, resulting in 1939 PGx visits. Of those visits, 1777 (92%) were referred by a primary care provider and 1675 (86.7%) were conducted by a primary care pharmacist. Twenty-nine primary care pharmacists offered the PGX service and 25 (89%) completed at least one visit. Patients were referred by providers from 56 of the 64 (87.5%) primary care departments. Conclusions: Developing an institutional process and guidance document for the implementation of a new pharmacist-led pharmacogenomics medication management service at clinic sites within an integrated health system was beneficial in developing and standardizing the workflow. Dissemination of workflow expectations to the primary care providers and pharmacists resulted in adoption of the service.
Keywords: Medication therapy management; collaborative practice agreement; pharmacogenomics; primary health care.
© Individual authors.
Figures
Similar articles
-
Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.J Am Board Fam Med. 2017 Nov-Dec;30(6):701-714. doi: 10.3122/jabfm.2017.06.170145. J Am Board Fam Med. 2017. PMID: 29180545 Clinical Trial.
-
Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).J Am Pharm Assoc (2003). 2018 May-Jun;58(3):281-289.e1. doi: 10.1016/j.japh.2018.02.011. Epub 2018 Mar 27. J Am Pharm Assoc (2003). 2018. PMID: 29602745 Clinical Trial.
-
Description of an Established, Fee-for-Service, Office-Based, Pharmacist-Managed Pharmacogenomics Practice.Sr Care Pharm. 2019 Dec 1;34(10):660-668. doi: 10.4140/TCP.n.2019.660. Sr Care Pharm. 2019. PMID: 31818351
-
Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):188-192. doi: 10.1016/j.japh.2022.09.002. Epub 2022 Sep 9. J Am Pharm Assoc (2003). 2023. PMID: 36243653 Review.
-
Applications for pharmacogenomics in pharmacy practice: A scoping review.Res Social Adm Pharm. 2022 Jul;18(7):3094-3118. doi: 10.1016/j.sapharm.2021.08.009. Epub 2021 Aug 20. Res Social Adm Pharm. 2022. PMID: 34474980
References
-
- Personalized Medicine. NIH National Genome Research Institute. Updated December 4, 2023. Accessed on December 5, 2023. https://www.genome.gov/genetics-glossary/Personalized-Medicine
LinkOut - more resources
Full Text Sources